MEI Pharma Inc (MEIP)
3.03
-0.11
(-3.50%)
USD |
NASDAQ |
Nov 13, 16:00
3.15
+0.12
(+3.96%)
After-Hours: 20:00
MEI Pharma Cash from Investing (Quarterly): 19.54M for June 30, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 19.54M |
March 31, 2024 | 0.122M |
December 31, 2023 | 24.52M |
September 30, 2023 | 4.957M |
June 30, 2023 | 19.40M |
March 31, 2023 | 10.02M |
December 31, 2022 | 10.53M |
September 30, 2022 | 13.74M |
June 30, 2022 | 20.11M |
March 31, 2022 | 15.16M |
December 31, 2021 | -43.37M |
September 30, 2021 | 14.99M |
June 30, 2021 | 9.988M |
March 31, 2021 | 15.39M |
December 31, 2020 | -5.144M |
September 30, 2020 | 4.476M |
June 30, 2020 | -85.05M |
March 31, 2020 | 9.103M |
December 31, 2019 | -35.32M |
September 30, 2019 | 4.967M |
June 30, 2019 | 9.955M |
March 31, 2019 | 9.768M |
December 31, 2018 | -0.193M |
September 30, 2018 | 4.788M |
June 30, 2018 | -59.43M |
Date | Value |
---|---|
March 31, 2018 | 5.098M |
December 31, 2017 | 4.963M |
September 30, 2017 | 5.042M |
June 30, 2017 | -0.04M |
March 31, 2017 | -5.012M |
December 31, 2016 | 5.008M |
September 30, 2016 | -10.03M |
June 30, 2016 | 0.029M |
March 31, 2016 | 5.002M |
December 31, 2015 | 0.026M |
September 30, 2015 | 4.915M |
June 30, 2015 | 4.999M |
March 31, 2015 | 4.99M |
December 31, 2014 | -30.04M |
September 30, 2014 | 9.995M |
June 30, 2014 | -0.038M |
March 31, 2014 | -15.02M |
December 31, 2013 | -20.00M |
September 30, 2013 | -0.006M |
June 30, 2013 | -0.01M |
March 31, 2013 | -0.024M |
December 31, 2012 | -0.002M |
September 30, 2012 | -0.002M |
June 30, 2012 | 0.00 |
March 31, 2012 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-85.05M
Minimum
Jun 2020
24.52M
Maximum
Dec 2023
1.219M
Average
10.02M
Median
Mar 2023
Cash from Investing (Quarterly) Benchmarks
Avid Bioservices Inc | -1.311M |
Evoke Pharma Inc | -- |
Revance Therapeutics Inc | 23.29M |
NovaBay Pharmaceuticals Inc | -0.002M |
Palatin Technologies Inc | -0.0049M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -18.00M |
Cash from Financing (Quarterly) | -0.208M |
Free Cash Flow | -50.48M |
Free Cash Flow Per Share (Quarterly) | -2.701 |
Free Cash Flow Yield | -250.0% |